Fetal and neonatal thrombopoietin levels in alloimmune thrombocytopenia

Pediatric Research

Volumn 52, Issue 1, 2002, Pages 105-108

  Porcelijn, L ^a   Folman, C C ^a   De Haas, M ^a   Kanhai, H H H ^b   Murphy, M F ^c   Von Dem Borne, A E G Kr ^d   Bussel, J B ^e  

^a CENTRAL LABORATORY   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOPOIETIC GROWTH FACTOR; THROMBOPOIETIN;

ALLOIMMUNIZATION; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; FETUS; HEMOLYTIC ANEMIA; HUMAN; MEASUREMENT; MEGAKARYOCYTE; NEWBORN; NORMAL HUMAN; PLASMA; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTOPENIA; THROMBOCYTOPOIESIS; UMBILICAL CORD;

EID: 0036081206     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-200207000-00019     Document Type: Article

References (26)

1. Thrombopoietin
2. The Mp1 receptor is expressed in the megakaryocytic lineage from late progenitors to platelets
3. Human platelets display high affinity receptors for thrombopoietin
4. Analysis of the kinetics of thrombopoietin uptake during platelet transfusion
5. Human platelets as a model for the binding and degradation of thrombopoietin
6. Interaction of thrombopoietin with the platelet c-mp1 receptor in plasma: Binding, internalization, stability and pharmacokinetics
7. A sensitive ELISA for measuring thrombopoietin in human serum: Serum thrombopoietin levels in healthy volunteers and in patients with haematopoietic disorders
8. Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction
9. Circulating thrombopoietin level in chronic immune thrombocytopenic purpura
10. The diagnostic value of thrombopoietin levels measurements in thrombocytopenia
11. High-level expression of Mp1 in platelets and megakaryocytes is independent of thrombopoietin
12. 348 Cases of suspected neonatal alloimmune thrombocytopenia
13. The natural history of fetomatemal alloimmunization to the platelet-specific antigen HPA-1a (PIAI, Zwa) as determined by antenatal screening
14. Neonatal alloimmune thrombocytopenia: Detection and characterization of the responsible antibodies by the platelet immunofluorescence test
15. In vitro culture of colony forming unit-megakaryocyte (CFU-MK) in fetal alloimmune thrombocytopenia
16. Neonatal alloimmune amegakaryocytosis. Case report
17. Diagnostic significance of the number of bone marrow megakaryocytes in cases with decreased platelet production evidenced by platelet kinetic study
18. Fetal alloimmune thrombocytopenia
19. Antenatal care in pregnancies at risk of alloimmune thrombocytopenia: Report of 19 cases in 16 families
20. Sensitive measurements of thrombopoietin by a monoclonal antibody based sandwich enzyme-linked immunosorbent assay
21. Thrombopoietin (Tpo) in the fetus and neonate: Tpo concentrations in preterm and term neonates, and organ distribution of Tpo and its receptor (c-mp1) during human fetal development
22. Age-related changes in thrombopoietin in children: Reference interval for serum thrombopoietin levels
23. Expression of the thrombopoietin gene in human fetal and neonatal tissues
24. Quantitative analysis of thrombopoietin receptors on human megakaryocytes
25. Treatment of thrombocytopenia in chimpanzees infected with human immunodeficiency virus by pegylated recombinant human megakaryocyte growth and development factor
26. Physiology and clinical applications of platelet growth factors